MarketCap
Facebook
X
TelegramQuarterly report 2022-Q2
added 08-09-2022
Epizyme Total Inventories 2011-2025 | EPZM
Quarterly Total Inventories Epizyme
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.52 M | 1.07 M | - | 10.5 M | - | 10.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.5 M | 1.07 M | 5.88 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Amphastar Pharmaceuticals
AMPH
|
154 M | $ 25.37 | -2.07 % | $ 1.23 B |  USA |
 |
Aclaris Therapeutics
ACRS
|
791 K | $ 3.28 | -2.53 % | $ 254 M | USA |
 |
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | USA |
 |
Aptorum Group Limited
APM
|
39.1 K | $ 1.31 | -1.88 % | $ 7.14 M |  China |
 |
Anika Therapeutics
ANIK
|
46.4 M | $ 9.56 | 0.75 % | $ 140 M | USA |
 |
BeiGene, Ltd.
BGNE
|
495 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Berkeley Lights
BLI
|
18.9 M | - | -7.31 % | $ 87 M | USA |
 |
Aytu BioScience
AYTU
|
11.4 M | $ 2.35 | 3.07 % | $ 14.8 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
6.71 M | - | -6.81 % | $ 3.04 B | USA |
 |
Baudax Bio
BXRX
|
5 M | - | 0.59 % | $ 63 K | USA |
 |
ChromaDex Corporation
CDXC
|
9.19 M | - | -0.88 % | $ 598 M | USA |
 |
Axon Enterprise
AXON
|
265 M | $ 568.3 | -2.19 % | $ 43 B | USA |
 |
Caladrius Biosciences
CLBS
|
1.27 M | - | -16.75 % | $ 25.8 M | USA |
 |
Clovis Oncology
CLVS
|
13.7 M | - | -7.23 % | $ 13 M | USA |
 |
Biogen
BIIB
|
2.46 B | $ 174.78 | 1.32 % | $ 25.4 B | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
21.2 M | - | - | $ 2.18 B | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
80.6 M | $ 11.5 | 0.52 % | $ 744 M | USA |
 |
Catalyst Biosciences
CBIO
|
4.28 M | $ 14.62 | -4.54 % | $ 962 M | USA |
 |
Cerus Corporation
CERS
|
38.2 M | $ 2.17 | 0.7 % | $ 401 M | USA |
 |
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | USA |